Jee Hyun Kim

Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial

Sung‐Bum Kang, Ji Won Park, Seung‐Yong Jeong et al. · The Lancet Oncology · 2010 · 1K citations

Medicine, Oncology, Surgery +17

Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial

Seung‐Yong Jeong, Ji Won Park, Byung Ho Nam et al. · The Lancet Oncology · 2014 · 889 citations

Medicine, Oncology, Surgery +17

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Sae‐Won Han, Tae‐You Kim, Pil Gyu Hwang et al. · Journal of Clinical Oncology · 2005 · 775 citations · Full text

Medicine, Oncology, Pharmacology +17

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Sung‐Bae Kim, Rebecca Dent, Seock‐Ah Im et al. · The Lancet Oncology · 2017 · 474 citations · Full text

Medicine, Oncology, Pharmacology +15

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17